Faculty profile

Subodh Verma

ResearcherAnesthesiologyUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Subodh Verma

Researcher

Anesthesiology

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
255 publications in the last five years, latest in 2026.
Senior (last) author on 63 recent papers, a sign of leading a research group.
Principal investigator on 13 research grants (13 CIHR), most recently in 2025.
Supervised 4 trainees who won CIHR awards, most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

396

Publications

6,675

Citations

h-index

102

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Crc Angiogenesis Hematopoietic Progenitor Cells Oxidative Stress Brca1 Gene Delivery (Aav9-Brca1)Heart Failure Murine Genotoxic Stress Model

Latest papers

Commentary: More arteries, better outcomes: A Latin American perspective on multiarterial grafting in coronary artery bypass grafting.
The Journal of thoracic and cardiovascular surgery · 2026 · first author
Rationale and Design of the Canadian Lipoprotein(a) Registry.
CJC open · 2026
Reducing opioid exposure after cardiac surgery with parasternal intercostal plane blocks (EPOCH CardioLink-10)-authors' response.
Lancet regional health. Americas · 2026 · senior author

All 396 publications

Latest funding

Efficacy of Intermittent Superficial Parasternal Intercostal Plane Block on Postoperative Pain Control in Patients Undergoing Cardiac Surgery with Median Sternotomy
CIHR · 2025 · Principal investigator
$374,850
Functional implications of vascular regenerative cell exhaustion in South Asian individuals with elevated cardiovascular disease risk
CIHR · 2024 · Nominated PI
$1,027,780
Canada Research Chair - Tier 1
CIHR · 2024 · Nominated PI
$1,400,000

All 20 grants and awards

From the 150 most recent of 396 publications.

Commentary: More arteries, better outcomes: A Latin American perspective on multiarterial grafting in coronary artery bypass grafting.

Verma S, Patel SK, Gaudino M, Puskas JD

The Journal of thoracic and cardiovascular surgery2026First author

DOI: 10.1016/j.jtcvs.2025.07.021 PMID: 40684847

Rationale and Design of the Canadian Lipoprotein(a) Registry.

Kramer AI, Abdel-Qadir H, Abramson BL, Baass A, Bergeron J, Bollu A, Cermakova L, Couture P, Fordyce CB, Gupta M, Hegele RA, Mancini GBJ, McPherson R, Moulson N, Pearson GJ, Roston T, Ruel I, Sedlak T, Sherman MH, Thanassoulis G, Udell JA, Verma S, Wan D, Iatan I, Brunham LR

CJC open2026

DOI: 10.1016/j.cjco.2026.06.003 PMID: 42756755

Reducing opioid exposure after cardiac surgery with parasternal intercostal plane blocks (EPOCH CardioLink-10)-authors' response.

Alli A, Mazer CD, Verma S, EPOCH CardioLink-10 Investigators

Lancet regional health. Americas2026Senior author

DOI: 10.1016/j.lana.2026.101611 PMID: 42725087

Effect of Evolocumab on Grafts Post-Coronary Artery Bypass Surgery: Post-Hoc Analysis of Newton-CABG CardioLink-5.

Mancini GBJ, Kamimura C, Szarek M, Yeoh E, Ryomoto A, Teoh H, Quan A, Elituv R, Verma M, Misner E, Saha T, Yanagawa B, Jüni P, Koren MJ, Nicholls SJ, Bhatt DL, Leiter LA, Mazer CD, Verma S

JACC. Advances2026Senior author

DOI: 10.1016/j.jacadv.2026.103162 PMID: 42617487

CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1.

Verma S, Böttcher M, Brown P, Dicker D, Rubino D, Sbraccia P, Sharma AM, Smedegaard L, Sørrig R, Garvey WT

Hypertension (Dallas, Tex. : 1979)2026First author

DOI: 10.1161/hypertensionaha.125.26055 PMID: 41328546

Empagliflozin in Heart Failure and Previous Coronary Revascularization: Insights From EMPEROR-Pooled.

Dhingra NK, Butler J, Anker SD, Ferreira JP, Filippatos G, Pfarr E, Gasior T, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M, Verma S, EMPEROR-Pooled Trial Committees and Investigators

JACC. Advances2026Senior author

DOI: 10.1016/j.jacadv.2025.102419 PMID: 41609275

Clinical Evidence of Cardioprotective Effects of SGLT2 Inhibitors.

Usman MS, Verma S, Pandey A

Handbook of experimental pharmacology2026

DOI: 10.1007/164_2026_827 PMID: 42730804

Vascular Regenerative Cell Flux in Diabetes: Mechanistic and Clinical Implications.

Dennis F, Dennis CJ, Quan A, Teoh H, Cosentino F, Verma S, Hess DA

Diabetes2026

DOI: 10.2337/db26-0372 PMID: 42574077

Effect of In-Hospital Initiation of Dapagliflozin on Decongestion in Patients Hospitalized for Heart Failure: An Analysis of the DAPA ACT HF-TIMI 68 Trial.

Small AM, Patel SM, Thomas C, Palazzolo MG, Bělohlávek J, Desai AS, Drożdż J, Inzucchi SE, McMurray JJV, Merkely B, O'Meara E, Verma S, Wiviott SD, Sabatine MS, Berg DD

JACC. Heart failure2026

DOI: 10.1016/j.jchf.2026.103366 PMID: 42669075

Benefit of Sotagliflozin Across the Full Range of Baseline Blood Pressure in the SOLOIST-WHF Trial.

Zitelny E, Bhatt DL, Verma S, Szarek M, Leiter LA, Lopes RD, Davies MJ, Girard M, Steg PG, Pitt B

JACC. Heart failure2026

DOI: 10.1016/j.jchf.2026.103368 PMID: 42670741

Something wrong or missing on this profile? Suggest a correction

Subodh Verma

Research

Latest papers

Latest funding

Commentary: More arteries, better outcomes: A Latin American perspective on multiarterial grafting in coronary artery bypass grafting.

Rationale and Design of the Canadian Lipoprotein(a) Registry.

Reducing opioid exposure after cardiac surgery with parasternal intercostal plane blocks (EPOCH CardioLink-10)-authors' response.

Effect of Evolocumab on Grafts Post-Coronary Artery Bypass Surgery: Post-Hoc Analysis of Newton-CABG CardioLink-5.

CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1.

Empagliflozin in Heart Failure and Previous Coronary Revascularization: Insights From EMPEROR-Pooled.

Clinical Evidence of Cardioprotective Effects of SGLT2 Inhibitors.

Vascular Regenerative Cell Flux in Diabetes: Mechanistic and Clinical Implications.

Effect of In-Hospital Initiation of Dapagliflozin on Decongestion in Patients Hospitalized for Heart Failure: An Analysis of the DAPA ACT HF-TIMI 68 Trial.

Benefit of Sotagliflozin Across the Full Range of Baseline Blood Pressure in the SOLOIST-WHF Trial.

Frequent collaborators

Hwee Teoh

Bobby Yanagawa

Mohammed Al-Omran

Bernard Zinman

Abhinav Sharma

Charles De Mestral

Nadia Giannetti

Howard Leong-Poi

Nadine Shehata

Marc Ruel

Mansoor Husain

Justin Ezekowitz

Ahmed Kayssi

Muhammad Mamdani

Atul Verma

Harriette Van Spall

Jean-Claude Tardif

John Eikelboom

Eva Lonn

Jean-Claude Tardif

Jessica Spence

Richard Whitlock

Ayodele Odutayo

Paul Dorian

Hertzel Gerstein

Jeff Healey

Robert McKelvie

Emilie Belley-Cote

David Cherney

Gregory Curnew

Nadia Khan

Branko Braam

Kevin Bainey

Mohammad Qadura

Louise Pilote

Fahad Razak

Amol Verma

Hassan Mir

David Hess

Thao Huynh